BiVictriX Therapeutics PLC
LSE:BVX
Income Statement
Earnings Waterfall
BiVictriX Therapeutics PLC
Revenue
|
0
GBP
|
Operating Expenses
|
-2.8m
GBP
|
Operating Income
|
-2.8m
GBP
|
Other Expenses
|
487k
GBP
|
Net Income
|
-2.3m
GBP
|
Income Statement
BiVictriX Therapeutics PLC
Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|
Revenue | |||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||
Operating Expenses |
(2)
|
(3)
|
(3)
|
(3)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
|
Research & Development |
(1)
|
(2)
|
(2)
|
(2)
|
|
Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
|
Operating Income |
(2)
N/A
|
(3)
-76%
|
(3)
-13%
|
(3)
+5%
|
|
Pre-Tax Income | |||||
Interest Income Expense |
(1)
|
(1)
|
0
|
0
|
|
Non-Reccuring Items |
(0)
|
(0)
|
0
|
0
|
|
Pre-Tax Income |
(3)
N/A
|
(4)
-44%
|
(3)
+18%
|
(3)
+5%
|
|
Net Income | |||||
Tax Provision |
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(2)
|
(3)
|
(2)
|
(2)
|
|
Net Income (Common) |
(2)
N/A
|
(3)
-38%
|
(2)
+23%
|
(2)
+7%
|
|
EPS (Diluted) |
-0.06
N/A
|
-0.05
+17%
|
-0.04
+20%
|
-0.04
N/A
|